Skip to main content
. Author manuscript; available in PMC: 2021 Apr 1.
Published in final edited form as: Gastrointest Endosc. 2019 Dec 7;91(4):905–916.e4. doi: 10.1016/j.gie.2019.11.043

Table 4:

Interval CRC rate among CRC-free study patients at screening compared with published studies

Current study National Polyp Study3,36 Polyp Prevention Trial4,5,11 PLCO study6 KP 201435 KP 201942
Procedure used CLEAR colonoscopy All performed by study investigators Usual-care, community-based colonoscopy
Total patients (age, year) 26,011 (>40) 9,112 (NA) 37,175 (>35 years) 15,395 (50–75 years) 273,742 (≥50 years) 99,166 (50–75 years)
Indication Screening Diagnostic Screen/diagnostic Diagnostic 57% diagnostic Screening
Exclusions@ 1,003 (3.9%) 7694 (84.4%) 35,096 (94.4%) NA 49,900 (18.2%) -
CRC-free patients (adenoma status at screening) 25,008 (7,530 adenoma, 17,478 no-adenoma) 1,418 (adenoma patients) 2,079 (adenoma patients) 15,935 (7950 adenoma, 7985 no-adenoma) 223,842 (all patients) 99,166 (No-adenoma)
Mean age at colonoscopy (year, (SD)) 58.1 (±9.2) 61 (±10) 61.0 (±0.3) 64 (median) 64 (median) 55.6
Interval CRCs 67 5 14 196 712 184
Person-Years of Observation (PYO) (mean follow-up years) 200,834 (8.0) 8,401 (5.9) 7,620 (4.0) 189,891 (119) 927,523 (4.1) 417,987
Interval CRC/10,000 PYO a) All patients 3.34 - - 10.32 7.68 -
b) Adenoma patients 5.79 5.9 18.3 13.07 NA -
c) No adenoma 2.24 - - NA NA 4.4
P value, Current vs Comparison study* - 0.95 <0.0001 <0.0001 <0.0001 0.0004
Interval CRC rate ratio 1.0 1.0 3.2 3.1 2.3 2.0
@

See Supplementary Table 2 for the exclusion criteria applied in each study. NA: Not available for the category.

KP: Kaiser Permanente